Stepping into adulthood: The transition period

Hormone Research

Volumn 62, Issue SUPPL. 4, 2004, Pages 15-22

  Shalet, S ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Adolescence; Growth hormone; Growth hormone treatment; Puberty; Transition

Indexed keywords

RECOMBINANT GROWTH HORMONE;

BONE MASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DATA ANALYSIS; DISEASE SEVERITY; GROWTH HORMONE DEFICIENCY; HUMAN; MEDICAL PRACTICE; MUSCLE MASS; PRIORITY JOURNAL;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ADULT; DRUG ADMINISTRATION SCHEDULE; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; STEROID METABOLISM, INBORN ERRORS;

EID: 10644270218     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000080904     Document Type: Conference Paper

References (44)

1. Borges O: Isometric and isokinetic knee extension and flexion torque in men and women aged 20-70. Scand J Rehabil Med 1989;21:45-53.
2. Recker RR, Davies KM, Hinders SM, Heaney RP, Stegman MR, Kimmel DB: Bone gain in young adult women. JAMA 1992;268:2403-2408.
3. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118-123.
4. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S: The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-3083.
5. Hulthen L, Bengtsson BA, Sunnerhagen KS, Hallberg L, Grimby G, Johannsson G: GH is needed for the maturation of muscle mass and strength in adolescents. J Clin Endocrinol Metab 2001;86:4765-4770.
6. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE, Christiansen JS: Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet 1989;1:1221-1225.
7. Johannsson G, Grimby G, Sunnerhagen KS, Bengtsson BA: Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults. J Clin Endocrinol Metab 1997;82:2877-2884.
8. Rosén T, Hansson T, Granhed H, Szucs J, Bengtsson BÅ: Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinol (Copenh) 1993;129:201-206.
9. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF, Shalet SM: Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. J Clin Endocrinol Metab 2002;87:3368-3372.
10. Koranyi J, Svensson J, Gotherstrom G, Sunnerhagen KS, Bengtsson B, Johannsson G: Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. J Clin Endocrinol Metab 2001;86:4693-4699.
11. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT, Heaney RP: Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest 1994;93:799-808.
12. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Shaw NJ, Camacho-Hubner C, Dunger DB, Chetham TD, Savage MO, Monson JP: Arrested bone mineralisation in GHD adolescents at final height. Growth Horm IGF Res 2002;12:abstract 018.
13. Rutherford OM, Jones DA, Round JM, Buchanan CR, Preece MA: Changes in skeletal muscle and body composition after discontinuation of growth hormone treatment in growth hormone deficient young adults. Clin Endocrinol 1991;34:469-475.
14. Colle M, Auzerie J: Discontinuation of growth hormone therapy in growth-hormone-deficient patients: assessment of body fat mass using bioelectrical impedance. Horm Res 1993;39:192-196.
15. Ogle GD, Moore B, Lu PW, Craighead A, Briody JN, Cowell CT: Changes in body composition and bone density after discontinuation of growth hormone therapy in adolescence: an interim report. Acta Paediatr Suppl 1994;399:3-7.
16. Attanasio AF, Lamberts SW, Matranga AM, Birkett MA, Bates PC, Valk NK, Hilsted J, Bengtsson BÅ, Strasburger CJ: Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. J Clin Endocrinol Metab 1997;82:82-88.
17. Johannsson G, Albertsson-Wikland K, Bengtsson BÅ: Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. J Clin Endocrinol Metab 1999;84:4516-4524.
18. Fors H, Bjarnason R, Wirent L, Albertsson-Wikland K, Bosaeust L, Bengtsson BA, Johannsson G: Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents. Clin Endocrinol 2001;55:617-624.
19. Bengtsson BÅ, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG: Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 1993;76:309-317.
20. Bengtsson B-Å, Johannsson G: Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults. Lancet 1999;353:1898-1899.
21. Salomon F, Cuneo RC, Hesp R, Sonksen PH: The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. N Engl J Med 1989;321:1797-1803.
22. Rosen T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.
23. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM: Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 2001;357:425-431.
24. Carroll PV, Christ ER, Bengtsson BÅ, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T, Thorne M: Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab 1998;83:382-395.
25. Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN: Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 1999;84:453-457.
26. Rosen T, Wiren L, Wilhelmsen L, Wiklund I, Bengtsson BA: Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf ) 1994;40:111-116.
27. Bjork S, Jonsson B, Westphal O, Levin JE: Quality of life of adults with growth hormone deficiency: a controlled study. Acta Paediatr Scand Suppl 1989;356:55-59.
28. McGauley GA: Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 1989;356:70-72.
29. Ezzat S, Fear S, Gaillard RC, Gayle C, Marcovitz S, Mattioni T, Nussey S, Rees A, Svanberg E: Circulating IGF-I levels in monitoring and predicting efficacy during long-term GH treatment of GH-deficient adults. Eur J Endocrinol 2003;149:499-509.
30. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE, Shalet SM: Influences on quality of life in GH deficient adults and their effect on response to treatment. Clin Endocrinol 1999;51:565-573.
31. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO, Monson JP: The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. J Clin Endocrinol Metab 2003;88:1658-1663.
32. Tauber M, Jouret B, Cartault A, Lounis N, Gayrard M, Marcouyeux C, Pienkowski C, Oliver I, Moulin P, Otal P, Joffre F, Arnaud C, Rochiccioli P: Adolescents with partial growth hormone (GH) deficiency develop alterations of body composition after GH discontinuation and require follow-up. J Clin Endocrinol Metab 2003;88:5101-5106.
33. Hoffman DM, Nguyen TV, O'Sullivan AJ, Baxter RC, Ho KK: Diagnosis of growth hormone deficiency in adults. Lancet 1994;344:482-483.
34. Growth Hormone Research Society: Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-381.
35. Heufelder A: Bridging regional and global perspectives. Horm Res 2004;62(suppl 4):8-14.
36. Wolthers T, Hoffman DM, Nugent AG, Duncan MW, Umpleby M, Ho KK: Oral estrogen antagonizes the metabolic actions of growth hormone in growth hormone-deficient women. Am J Physiol Endocrinol Metab 2001;281:E1191-E1196.
37. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK: Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol 1993;39:561-567.
38. Anon: Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 2001;86:1868-1870.
39. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ, Hartman ML: Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002;87:2067-2079.
40. Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S, Mattioni T, Nussey S, Rees A, Svanberg E: Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults. J Clin Endocrinol Metab 2002;87:2725-2733.
41. Norrelund H, Vahl N, Juul A, Moller N, Alberti KG, Skakkebaek NE, Christiansen JS, Jorgensen JO: Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. J Clin Endocrinol Metab 2000;85:1912-1917.
42. Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G: The cardiovascular risk of GH-deficient adolescents. J Clin Endocrinol Metab 2002;87:3650-3655.
43. Underwood LE, Attie KM, Baptista J: Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. J Clin Endocrinol Metab 2003;88:5273-5280.
44. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalova J, Moshang T, Blum WF, Chipman JJ, Quigley CA, Attanasio AF: Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. J Clin Endocrinol Metab 2003;88:4124-4129.